MaxCyte (MXCT) 2025 Earnings Outlook for Investors
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
Explore ways to earn cash back on no annual fee cards. These strategies will help you maximize your savings and rewards.
23,562 articlesMaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
Investors are turning away from Hewlett Packard Enterprise as a dividend-rich tech giant with a clearer AI roadmap ga...
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
Johnson Johnson walking away from a GLP-1 obesity obsession signals a shift to a diversified, potentially more resili...
Warren Buffett's long-held Coca-Cola stake offers a blueprint for patient investing. Learn how durable moats, consist...
Choosing the right investing platform can save time and money. This guide shows how to pick tools that align with you...
CrowdStrike has shown momentum, but the stock carries risk. Here’s why I’m skeptical and how investors can approach c...
A viral Substack piece by a former EMT triggered rapid stock declines as AI fears spread. This article explains what ...
BitMine announces a sizable addition to its Ethereum stash, buying about 61,000 ETH and boosting holdings to about 4....
Industrial stocks right now offer solid exposure to infrastructure spending and manufacturing demand. Meet two top pi...
After a challenging stretch, small-cap stocks may be poised for a revival in 2026. This guide breaks down the signals...
Mega-IPOs grab headlines, but what sticks after the first week? This article breaks down the five biggest IPOs in his...